Quantcast

Latest Hodgkin's lymphoma Stories

2014-12-05 12:25:02

- Updated results from pilot Phase II trial of the BCL2 targeting DNAi® therapeutic reported at ASH 2014 - VANCOUVER, BC and PLYMOUTH, MI, Dec.

2014-12-05 08:25:08

U.S.-Based Registry Will Enhance Clinical Knowledge of and Explore Treatment Options for CLL Patients SUNNYVALE, Calif., Dec. 5, 2014 /PRNewswire/ -- Pharmacyclics, Inc.

2014-12-01 12:29:57

Company Supports Cancer Research With National In-Store Fundraiser and Sponsorship PLANO, Texas, Dec.

2014-11-17 23:02:06

Comprehensive market research report “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment

2014-11-17 08:29:50

PRINCETON, N.J., Nov. 17, 2014 /PRNewswire/ -- Soligenix, Inc.

2014-10-29 08:34:22

This Year Marks the 20th Anniversary of LLS's Prestigious Translational Research Program WHITE PLAINS, N.Y., Oct.

2014-10-29 08:32:28

DALLAS, October 29, 2014 /PRNewswire/ -- ReportsnReports.com adds Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline


Word of the Day
postliminy
  • In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
  • In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.
The word 'postliminy' comes from a Latin word meaning 'threshold'.